Zelira Therapeutics Ltd.ASX: ZLD

HOPE SPV receives US$681,000 third tranche of funding

· Issued by Zelira Therapeutics Ltd.

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Zelira Therapeutics Ltd. has announced the receipt of a third tranche of funding for its HOPE® SPV from the Forman Trust, totaling a significant amount. To date, the total funds received by the HOPE® SPV amount to a substantial figure, reflecting ongoing financial support for the project.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zelira Therapeutics Ltd. on 6ix

Earlier from Zelira Therapeutics

Later from Zelira Therapeutics

All Zelira Therapeutics news releases